The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

##STR00001##

The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

##STR00001##

The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. ##STR00001##

The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. ##STR00001##

A compound having formula 1 or a salt thereof:

##STR00001##

A method for making the compound having formula 1 includes a step of reacting dopamine.Math.HCL with hypochlorous acid in a reaction solvent to form the compound having formula 1 or a salt thereof. The reaction can take place in a polar or nonpolar solvent.

A compound having formula 1 or a salt thereof:

##STR00001##

A method for making the compound having formula 1 includes a step of reacting dopamine.Math.HCL with hypochlorous acid in a reaction solvent to form the compound having formula 1 or a salt thereof. The reaction can take place in a polar or nonpolar solvent.